PD
NVRO

Point72 (DIFC)’s NEVRO CORP. NVRO Stock Holding History

Point72 (DIFC)’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-684
Closed -$2.54K – 2148
2024
Q4 		$2.54K Sell
684
-916
-57% -$4.23K ﹤0.01% 1420
2024
Q3 		$8.94K Sell
1,600
-1,800
-53% -$12.6K ﹤0.01% 1273
2024
Q2 		$28.6K Sell
3,400
-4,120
-55% -$43.9K ﹤0.01% 1181
2024
Q1 		$109K Buy
+7,520
New +$124K ﹤0.01% 1079

Other funds holding NVRO

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 (DIFC)'s NVRO Position: Q1 2025 in Review

Point72 (DIFC) sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 684 shares — an estimated $2.54K sold.

Point72 (DIFC) first reported a position in NVRO in Q1 2024 and held it in 4 quarters. The position peaked at $109K in Q1 2024. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • Point72 (DIFC) reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 684 NEVRO CORP. shares in Q1 2025, an estimated $2.54K.
  • Point72 (DIFC) first reported a position in NEVRO CORP. in Q1 2024 and held it in 4 quarters.
  • Point72 (DIFC)'s NEVRO CORP. position peaked at $109K in Q1 2024.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Point72 (DIFC)'s 13F filing for Q1 2025, filed 15 May 2025.